Özcebe OI - Search Results

1

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome.

Göker H, Aladağ Karakulak E, Demiroğlu H, Ayaz Ceylan ÇM, Büyükaşik Y, Inkaya AÇ, Aksu S, Sayinalp N, Haznedaroğlu IC, Uzun Ö, Akova M, Özcebe OI, Ünal S. Göker H, et al. Among authors: ozcebe oi. Turk J Med Sci. 2020 Jun 23;50(4):679-683. doi: 10.3906/sag-2005-395. Turk J Med Sci. 2020. PMID: 32496734 Free PMC article.

2

Pancytopenia with hypocellular bone marrow due to miliary tuberculosis: an unusual presentation.

Demiroğlu H, Ozcebe OI, Ozdemir L, Sungur A, Dündar S. Demiroğlu H, et al. Among authors: ozcebe oi. Acta Haematol. 1994;91(1):49-51. doi: 10.1159/000204246. Acta Haematol. 1994. PMID: 8171938

3

Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia.

Haznedaroğlu IC, Ertenli I, Ozcebe OI, Kiraz S, Ozdemir O, Sayinalp NM, Dündar SV, Calgüneri M, Kirazli S. Haznedaroğlu IC, et al. Among authors: ozcebe oi. Acta Haematol. 1996;95(2):107-11. doi: 10.1159/000203857. Acta Haematol. 1996. PMID: 8638438

4

Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity.

Gürsoy M, Haznedaroğlu IC, Celik I, Sayinalp N, Ozcebe OI, Dündar SV. Gürsoy M, et al. Among authors: ozcebe oi. Ann Pharmacother. 1996 Jul-Aug;30(7-8):762-5. doi: 10.1177/106002809603000710. Ann Pharmacother. 1996. PMID: 8826556

5

Chronic lymphocytic leukemia presenting as acute urinary retention due to leukemic infiltration of the prostate.

Benekli M, Büyükaşik Y, Haznedaroğlu IC, Savaş MC, Ozcebe OI. Benekli M, et al. Among authors: ozcebe oi. Ann Hematol. 1996 Sep;73(3):143-4. doi: 10.1007/s002770050216. Ann Hematol. 1996. PMID: 8841103

6

Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.

Akova M, Ozcebe O, Güllü I, Unal S, Gür D, Akalin S, Tokgözoglu M, Telatar F, Akalin HE. Akova M, et al. J Chemother. 1996 Aug;8(4):284-9. doi: 10.1179/joc.1996.8.4.284. J Chemother. 1996. PMID: 8873834 Clinical Trial.

7

Cytokines in Behçet's disease.

Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroğlu IC, Dündar S, Kirazli S. Sayinalp N, et al. Among authors: ozcebe oi. J Rheumatol. 1996 Feb;23(2):321-2. J Rheumatol. 1996. PMID: 8882039

8

Impaired haemostatic kinetics and endothelial function in Behçet's disease.

Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dündar SV, Kirazli S. Haznedaroglu IC, et al. Among authors: ozcebe oi. J Intern Med. 1996 Oct;240(4):181-7. doi: 10.1046/j.1365-2796.1996.396853000.x. J Intern Med. 1996. PMID: 8918508

9

Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.

Sayinalp S, Akalin S, Sayinalp N, Erbaş T, Bayraktar M, Ozcebe OI, Dündar S, Kirazli S. Sayinalp S, et al. Among authors: ozcebe oi. Horm Metab Res. 1996 Mar;28(3):133-7. doi: 10.1055/s-2007-979145. Horm Metab Res. 1996. PMID: 8926012 Clinical Trial.

10

Mean platelet volume, platelet count and platelet dimensional width during hemodialysis.

Ozdemir O, Sayinalp NM, Haznedaroğlu I, Arik N, Ozcebe OI, Dündar S. Ozdemir O, et al. Among authors: ozcebe oi. Thromb Res. 1997 Jun 1;86(5):405-8. doi: 10.1016/s0049-3848(97)00085-6. Thromb Res. 1997. PMID: 9211631 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page